P
Palisade Bio, Inc. (PALI)
NCM – Real Time Price. Currency in USD
2.00
+0.04 (2.04%)
At close: Mar 27, 2026, 4:00 PM EDT
1.95
-0.05 (-2.44%)
After-hours: Mar 27, 2026, 7:32 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
2.00
+0.04 (2.04%)
At close: Mar 27, 2026, 4:00 PM EDT
1.95
-0.05 (-2.44%)
After-hours: Mar 27, 2026, 7:32 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 28.95 | 6.05 | 10 | |
| Quick ratio | 28.95 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | -4990.50 | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 250K | N/A | N/A | N/A |
| Gross Profit | -167K | 246K | -3K | -3K | -3K |
| Operating Income | -15M | -13M | -15M | -18M | -18M |
| Net Income | -15M | -12M | -14M | -17M | -17M |
| EBITDA | -15M | -13M | -15M | -18M | -18M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 92.34 | 5.5 |
| Next quarter | N/A | 91.38 | 5.5 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | -28.85 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -210.28 | 34.48 | 11.51 | 7.0 |
| Y/Y | 999 | -166.11 | 83.62 | -32.04 | 5.5 |
| 3y average | 632.67 | -6.02 | 75.69 | 6.09 | 6.5 |
| 5y average | 779.2 | -26.11 | 80.54 | -36.32 | 5.5 |
| Weighted average score | 6.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $133.4M significantly exceed its total debt $71.0K, ensuring strong financial flexibility
Total current assets $134.2M exceed Total current liabilities $4.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-4,990.5x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.1M limits the company's ability to reinvest or pay down debt